Current - 4 hours ago

* home

* portfolio

* approach

* team

* careers

* news

* contact

* investor portal

* home

* portfolio

* approach

* team

* careers

* news

* contact

* investor portal

Nextech Invest

portfolio

Guiding discoveries from validation to value.

We are a sought-after partner to innovators worldwide, who come to Nextech for our rigorous approach to scientific validation and our hands-on support for successful company development. We help our portfolio through critical moments of scientific and clinical validation, where we can have the greatest impact for patients and investors.

“Nextech offers a critical eye, both discerning and impactful, to our protein degradation approach, clinical development and partnering opportunities, and has done so since they began visiting us in New Haven years before investing. Their depth of knowledge and collaborative approach make Nextech an important partner for us.”

John G. Houston, Ph.D.

President and CEO

Arvinas, Inc.

“Nextech had the depth in oncology to quickly understand our science and how effective our targeted therapies could be. Equally important, they understand how to build great companies and are a valuable, level-headed sounding board as we build our team and craft a financial strategy aligned to our plan.”

Athena Countouriotis, MD

CEO & President

Turning Point Therapeutics

“The entire Nextech team added tremendous value to our efforts as a hands-on investor: with rigorous ongoing assessment of our discovery and development programs; refinement of our business strategy; and deep connections in the Biotech/Pharma industry.”

John Josey

CEO & President

Peloton

“The team at Nextech Invest brings a passion for oncology, science and patients that makes them a terrific partner. Blueprint Medicines has been fortunate to benefit from the early financial support and the ongoing strategic advice of the Nextech team.”

Jeff Albers

CEO & President

Blueprint Medicines

All

New

Private

Public

Acquired

private

public

private

private

private

private

public

private

private

public

public

public

private

public

public

private

private

public

private

public

private

private

private

private

private

public

private

private

public

private

public

public

public

acquired

private

acquired

acquired

public

acquired

public

private

private

public

private

public

public

private

public

public

acquired

© Nextech Invest Ltd. | privacy policy

© Nextech Invest Ltd. | privacy policy

This website uses cookies to provide you with the best possible service. By using our website, you consent to the use of cookies in accordance with our privacy policy . X

Privacy Policy

Close

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT